Earlier age at menarche is associated with higher diabetes risk and cardiometabolic disease risk factors in Brazilian adults: Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)

Cardiovascular Diabetology

Volumn 13, Issue 1, 2014, Pages

  Mueller, Noel T ^a,b,f   Duncan, Bruce B ^a   Barreto, Sandhi M ^d   Chor, Dora ^e   Bessel, Marina ^a   Aquino, Estela M L ^c   Pereira, Mark A ^f   Schmidt, Maria I ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^d FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^e INSTITUTO OSWALDO CRUZ   (Brazil)

^f UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Brazil; Cardiometabolic risk; Diabetes; Epidemiology; Menarche; Metabolic syndrome; Nutrition transition; Obesity; Primordial prevention; Puberty

Indexed keywords

ALANINE AMINOTRANSFERASE; C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BIRTH WEIGHT; BODY MASS; BRAZIL; CARDIOMETABOLIC RISK; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LEG LENGTH; MAJOR CLINICAL STUDY; MENARCHE; MIDDLE AGED; SELF REPORT; WAIST CIRCUMFERENCE;

ADULT; AGE FACTORS; AGED; BLOOD GLUCOSE; BRAZIL; CARDIOVASCULAR DISEASES; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH STATUS; HUMANS; LONGITUDINAL STUDIES; MENARCHE; MIDDLE AGED; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84892422128     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-13-22     Document Type: Article

References (48)

1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006, 367(9524):1747-1757. 10.1016/S0140-6736(06)68770-9, 16731270.
2. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, Lin JK, Farzadfar F, Khang YH, Stevens GA, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 2011, 378(9785):31-40. 10.1016/S0140-6736(11)60679-X, 21705069.
3. Danaei G, Lawes CM, Vander Hoorn S, Murray CJ, Ezzati M. Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment. Lancet 2006, 368(9548):1651-1659. 10.1016/S0140-6736(06)69700-6, 17098083.
4. Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011, 94(3):311-321. 10.1016/j.diabres.2011.10.029, 22079683.
5. Schmidt MI, Duncan BB, Azevedo e Silva G, Menezes AM, Monteiro CA, Barreto SM, Chor D, Menezes PR. Chronic non-communicable diseases in Brazil: burden and current challenges. Lancet 2011, 377(9781):1949-1961. 10.1016/S0140-6736(11)60135-9, 21561658.
6. Aguayo-Tellez E, Muendler MA, Poole JP. Globalization and Formal Sector Migration in Brazil. World Dev 2010, 38(6):840-856.
7. Monteiro CA, Conde WL, Popkin BM. The burden of disease from undernutrition and overnutrition in countries undergoing rapid nutrition transition: a view from Brazil. Am J Public Health 2004, 94(3):433-434. 10.2105/AJPH.94.3.433, 1448269, 14998807.
8. Fabricatore AN. Behavior therapy and cognitive-behavioral therapy of obesity: is there a difference?. J Am Diet Assoc 2007, 107(1):92-99. 10.1016/j.jada.2006.10.005, 17197276.
9. Wadden TA, Webb VL, Moran CH, Bailer BA. Lifestyle modification for obesity: new developments in diet, physical activity, and behavior therapy. Circulation 2012, 125(9):1157-1170. 10.1161/CIRCULATIONAHA.111.039453, 3313649, 22392863.
10. Wing RR, Bolin P, Brancati FL, Bray GA, Clark JM, Coday M, Crow RS, Curtis JM, Egan CM, Espeland MA, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med 2013, 369(2):145-154.
11. Mishra GD, Cooper R, Tom SE, Kuh D. Early life circumstances and their impact on menarche and menopause. Womens Health (Lond Engl) 2009, 5(2):175-190. 10.2217/17455057.5.2.175, 3287288, 19245355.
12. Lorentzon M, Norjavaara E, Kindblom JM. Pubertal timing predicts leg length and childhood body mass index predicts sitting height in young adult men. J Pediatr 2011, 158(3):452-457. 10.1016/j.jpeds.2010.09.009, 20961561.
13. Junqueira Do Lago M, Faerstein E, De Souza Lopes C, Werneck GL. Family socio-economic background modified secular trends in age at menarche: evidence from the Pro-Saude Study (Rio de Janeiro, Brazil). Ann Hum Biol 2003, 30(3):347-352. 10.1080/0301446031000091783, 12850966.
14. Wronka I, Pawlinska-Chmara R. Menarcheal age and socio-economic factors in Poland. Ann Hum Biol 2005, 32(5):630-638. 10.1080/03014460500204478, 16316918.
15. Ellis BJ, Garber J. Psychosocial antecedents of variation in girls' pubertal timing: maternal depression, stepfather presence, and marital and family stress. Child Dev 2000, 71(2):485-501. 10.1111/1467-8624.00159, 10834479.
16. Padez C. Social background and age at menarche in Portuguese university students: a note on the secular changes in Portugal. Am J Hum Biol 2003, 15(3):415-427. 10.1002/ajhb.10159, 12704717.
17. Pantsiotou S, Papadimitriou A, Douros K, Priftis K, Nicolaidou P, Fretzayas A. Maturational tempo differences in relation to the timing of the onset of puberty in girls. Acta Paediatr 2008, 97(2):217-220. 10.1111/j.1651-2227.2007.00598.x, 18177444.
18. Kac G, Auxiliadora de Santa Cruz C, Velasquez-Melendez G. Secular trend in age at menarche for women born between 1920 and 1979 in Rio de Janeiro, Brazil. Ann Hum Biol 2000, 27(4):423-428. 10.1080/03014460050044892, 10942349.
19. Stockl D, Doring A, Peters A, Thorand B, Heier M, Huth C, Stockl H, Rathmann W, Kowall B, Meisinger C. Age at menarche is associated with prediabetes and diabetes in women (aged 32-81 years) from the general population: the KORA F4 study. Diabetologia 2012, 55(3):681-688. 10.1007/s00125-011-2410-3, 22170465.
20. Dreyfus JG, Lutsey PL, Huxley R, Pankow JS, Selvin E, Fernandez-Rhodes L, Franceschini N, Demerath EW. Age at menarche and risk of type 2 diabetes among African-American and white women in the Atherosclerosis Risk in Communities (ARIC) study. Diabetologia 2012, 55(9):2371-2380. 10.1007/s00125-012-2616-z, 3690318, 22760786.
21. He C, Zhang C, Hunter DJ, Hankinson SE, Buck Louis GM, Hediger ML, Hu FB. Age at menarche and risk of type 2 diabetes: results from 2 large prospective cohort studies. Am J Epidemiol 2010, 171(3):334-344. 10.1093/aje/kwp372, 2842205, 20026580.
22. Pierce MB, Kuh D, Hardy R. The role of BMI across the life course in the relationship between age at menarche and diabetes, in a British birth cohort. Diabet Med 2012, 29(5):600-603. 10.1111/j.1464-5491.2011.03489.x, 3397674, 21999522.
23. Lakshman R, Forouhi N, Luben R, Bingham S, Khaw K, Wareham N, Ong KK. Association between age at menarche and risk of diabetes in adults: results from the EPIC-Norfolk cohort study. Diabetologia 2008, 51(5):781-786. 10.1007/s00125-008-0948-5, 18320165.
24. Conway BN, Shu XO, Zhang X, Xiang YB, Cai H, Li H, Yang G, Gao YT, Zheng W. Age at menarche, the leg length to sitting height ratio, and risk of diabetes in middle-aged and elderly Chinese men and women. PLoS One 2012, 7(3):e30625. 10.1371/journal.pone.0030625, 3309033, 22448212.
25. Mueller NT, Odegaard AO, Gross MD, Koh WP, Yuan JM, Pereira MA. Age at menarche and cardiovascular disease mortality in Singaporean Chinese women: the Singapore Chinese health study. Ann Epidemiol 2012, 22(10):717-722. 10.1016/j.annepidem.2012.08.002, 3459135, 22939833.
26. Qiu C, Chen H, Wen J, Zhu P, Lin F, Huang B, Wu P, Lin Q, Lin Y, Rao H, et al. Associations between age at menarche and menopause with cardiovascular disease, diabetes, and osteoporosis in Chinese women. J Clin Endocrinol Metab 2013, 98(4):1612-1621. 10.1210/jc.2012-2919, 23471979.
27. Aquino EM, Barreto SM, Bensenor IM, Carvalho MS, Chor D, Duncan BB, Lotufo PA, Mill JG, Molina Mdel C, Mota EL, et al. Brazilian Longitudinal Study of Adult Health (ELSA-Brasil): objectives and design. Am J Epidemiol 2012, 175(4):315-324. 10.1093/aje/kwr294, 22234482.
28. Must A, Phillips SM, Naumova EN, Blum M, Harris S, Dawson-Hughes B, Rand WM. Recall of early menstrual history and menarcheal body size: after 30 years, how well do women remember?. Am J Epidemiol 2002, 155(7):672-679. 10.1093/aje/155.7.672, 11914195.
29. Spiegelman D, Hertzmark E. Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol 2005, 162(3):199-200. 10.1093/aje/kwi188, 15987728.
30. Bogin B, Varela-Silva MI. Leg length, body proportion, and health: a review with a note on beauty. Int J Environ Res Public Health 2010, 7(3):1047-1075. 10.3390/ijerph7031047, 2872302, 20617018.
31. Monteiro CA, Benicio MH, Gouveia Nda C. Secular growth trends in Brazil over three decades. Ann Hum Biol 1994, 21(4):381-390. 10.1080/03014469400003372, 8080238.
32. Estatistica IBdGe Pesquisa de Orçamentos Familiares 2008-2009 2010, Rio de Janeiro, Brasil: Instituto Brasileiro de Geografi a e Estatística - IBGE, August 27, 2010, http://www.ibge.gov.br/home/estatistica/populacao/condicaodevida/pof/2008_2009_analise_consumo/pofanalise_2008_2009.pdf, Estatistica IBdGe.
33. Elks CE, Ong KK, Scott RA, van der Schouw YT, Brand JS, Wark PA, Amiano P, Balkau B, Barricarte A, Boeing H, et al. Age at menarche and type 2 diabetes risk: the EPIC-InterAct study. Diabetes Care 2013, 36(11):3526-3534. 10.2337/dc13-0446, 24159179.
34. Kaplowitz PB. Link between body fat and the timing of puberty. Pediatrics 2008, 121(Suppl 3):S208-S217.
35. Dunger DB, Ahmed ML, Ong KK. Early and late weight gain and the timing of puberty. Mol Cell Endocrinol 2006, 254-255:140-145.
36. Wilson ME, Fisher J, Chikazawa K, Yoda R, Legendre A, Mook D, Gould KG. Leptin administration increases nocturnal concentrations of luteinizing hormone and growth hormone in juvenile female rhesus monkeys. J Clin Endocrinol Metab 2003, 88(10):4874-4883. 10.1210/jc.2003-030782, 14557468.
37. Kitawaki J, Kusuki I, Koshiba H, Tsukamoto K, Honjo H. Leptin directly stimulates aromatase activity in human luteinized granulosa cells. Mol Hum Reprod 1999, 5(8):708-713. 10.1093/molehr/5.8.708, 10421796.
38. Thankamony A, Ong KK, Ahmed ML, Ness AR, Holly JM, Dunger DB. Higher levels of IGF-I and adrenal androgens at age 8 years are associated with earlier age at menarche in girls. J Clin Endocrinol Metab 2012, 97(5):E786-E790. 10.1210/jc.2011-3261, 3444968, 22419724.
39. Ibanez L, Lopez-Bermejo A, Diaz M, Marcos MV, de Zegher F. Early metformin therapy to delay menarche and augment height in girls with precocious pubarche. Fertil Steril 2011, 95(2):727-730. 10.1016/j.fertnstert.2010.08.052, 20883985.
40. Ibanez L, Lopez-Bermejo A, Diaz M, Marcos MV, de Zegher F. Early metformin therapy (age 8-12 years) in girls with precocious pubarche to reduce hirsutism, androgen excess, and oligomenorrhea in adolescence. J Clin Endocrinol Metab 2011, 96(8):E1262-E1267. 10.1210/jc.2011-0555, 21632811.
41. Ibanez L, Ong K, Valls C, Marcos MV, Dunger DB, de Zegher F. Metformin treatment to prevent early puberty in girls with precocious pubarche. J Clin Endocrinol Metab 2006, 91(8):2888-2891. 10.1210/jc.2006-0336, 16684823.
42. Ibanez L, Valls C, Ong K, Dunger DB, de Zegher F. Metformin therapy during puberty delays menarche, prolongs pubertal growth, and augments adult height: a randomized study in low-birth-weight girls with early-normal onset of puberty. J Clin Endocrinol Metab 2006, 91(6):2068-2073. 10.1210/jc.2005-2329, 16492692.
43. Vanni E, Bugianesi E, Kotronen A, De Minicis S, Yki-Jarvinen H, Svegliati-Baroni G. From the metabolic syndrome to NAFLD or vice versa?. Dig Liver Dis 2010, 42(5):320-330. 10.1016/j.dld.2010.01.016, 20207596.
44. Feng Y, Hong X, Wilker E, Li Z, Zhang W, Jin D, Liu X, Zang T, Xu X, Xu X. Effects of age at menarche, reproductive years, and menopause on metabolic risk factors for cardiovascular diseases. Atherosclerosis 2008, 196(2):590-597. 10.1016/j.atherosclerosis.2007.06.016, 2271121, 17675039.
45. Stockl D, Meisinger C, Peters A, Thorand B, Huth C, Heier M, Rathmann W, Kowall B, Stockl H, Doring A. Age at menarche and its association with the metabolic syndrome and its components: results from the KORA F4 study. PLoS One 2011, 6(10):e26076. 10.1371/journal.pone.0026076, 3196515, 22028807.
46. Glueck CJ, Morrison JA, Wang P, Woo JG. Early and late menarche are associated with oligomenorrhea and predict metabolic syndrome 26 years later. Metabolism 2013, 62(11):1597-1606. 10.1016/j.metabol.2013.07.005, 23953892.
47. Akter S, Jesmin S, Islam M, Sultana SN, Okazaki O, Hiroe M, Moroi M, Mizutani T. Association of age at menarche with metabolic syndrome and its components in rural Bangladeshi women. Nutr Metab 2012, 9(1):99.
48. Herman KM, Craig CL, Gauvin L, Katzmarzyk PT. Tracking of obesity and physical activity from childhood to adulthood: the physical activity longitudinal study. Int J Pediatr Obes 2009, 4(4):281-288. 10.3109/17477160802596171, 19922043.